Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

Abstract Title:

REGENERATION OF INFARCTED MYOCARDIUM WITH RESVERATROL-MODIFIED CARDIAC STEM CELLS.

Abstract Source:

J Cell Mol Med. 2011 Feb 25. Epub 2011 Feb 25. PMID: 21352470

Abstract Author(s):

Nikolai Gorbunov, Goran Petrovski, Narasimman Gurusamy, Diptarka Ray, Do Han Kim, Dipak K Das

Article Affiliation:

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20889-5603, USA University of Debrecen, Department of Biochemistry and Molecular Biology, Debrecen, Hungary University of Connecticut School of Medicine, Cardiovascular Research Center, Farmington, Connecticut, USA.

Abstract:

The major problem in stem cell therapy includes viability and engraftment efficacy of stem cells after transplantation. Indeed, the vast majority of host-transfused cells do not survive beyond 24 to 72 hours. In order to increase the survival and engraftment of implanted cardiac stem cells in the host, we developed a technique of treating these cells with resveratrol, and tested it in a rat model of LAD (left anterior descending) occlusion. Multipotent clonogenic cardiac stem cells isolated from rat heart and stably transfected with EGFP were pre-treated with 2.5μM resveratrol for 60 minutes. Rats were anesthetized, hearts opened and the LAD occluded to induce heart attack. One week later, the cardiac reduced environment was confirmed in resveratrol treated rat hearts by the enhanced expression of nuclear factor-E2-related factor-2 (Nrf2) and redox effector factor-1 (Ref-1). M-mode echocardiography after stem cell therapy, showed improvement in cardiac function (left ventricular ejection fraction, fractional shortening and cardiac output) in both, the treated and control group after 7 days, but only resveratrol-modified stem cell group revealed improvement in cardiac function at the end of one, two and four months time. The improvement of cardiac function was accompanied by enhanced stem cell survival and engrafment as evidenced by the expression of cell proliferation marker Ki67 and differentiation of stem cells towards the regeneration of themyocardium as evidenced by the expression of EGFP up to four months after LAD occlusion in the resveratrol treated stem cell group. Expression of stromal cell-derived factor (SDF-1) and myosin conclusively demonstrated homing of stem cells in the infarcted myocardium, its regeneration leading to improvement of cardiac function.

Study Type : In Vitro Study

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.